HEALTH CARE BRIEFING: House Eyes Drug Cost Cap in Employer Plans

House Democrats agree with employer, labor and consumer groups that commercial health plans should be included in sweeping health-care legislation designed to curb drug prices, according to sources.

Whether plans sponsored by employers or insurers can be covered under H.R. 3‘s proposed cap on drug price inflation will depend on whether the addition is allowed under a budget reconciliation procedure that Congress will use to advance expanded Medicare benefits in the fall.

“We’re trying to see if we can make that work this year,” said a House Democratic aide who spoke on condition of anonymity. “We haven’t resolved it completely, but we’re trying.”

The House drug pricing bill is designed to offset the cost of the expanded benefits by cutting what Medicare pays for prescription drugs. The bill’s chief driver of the lower prices is a provision that permits the federal government to negotiate directly with drug manufacturers on how much it pays for high-priced products. Commercial plans—run by employers, insurers, and labor unions—would pay the same amount for those drugs.

The bill also would require pharmaceutical companies to rebate to the Treasury Department the amount that they raise prices for certain drugs above inflation. Employers and labor unions want such rebates in commercial plans as well. Without them, they say, they would be susceptible to large price spikes in prescriptions. They’ve been discussing the issue with House leaders for months, according to a source involved in the talks.

Republicans don’t support the legislation, so the only path to passage is a budget process called reconciliation that bypasses the need for 60 votes in the Senate. Only policies that change spending or revenues can be included in budget reconciliation bills, so lawmakers would need to write the commercial insurance provision such that it affects the budget.

If the Senate’s parliamentarian doesn’t rule that the provision is primarily budgetary, “that provision which applies the inflation rebate to the commercial sector would have to be dropped,” the House aide said. “We haven’t made a final determination of the language,” the aide said. “I think we’re going to put it in there.” Read more from Sara Hansard.

Also on Lawmakers’ Radars

HELP Markup: The Senate Health, Education, Labor and Pensions Committee is scheduled to mark up four bills including:

• S. 1486, to eliminate discrimination and promote women’s health and economic security by ensuring reasonable workplace accommodations for workers whose ability to perform the functions of a job are limited by pregnancy, childbirth, or a related medical condition; and
• S. 1543, to provide best practices on student suicide awareness and prevention training and to condition state educational agencies, local educational agencies, and tribal educational agencies to establish and implement a school-based student suicide awareness and prevention training policy.

Infections a Hurdle to Infrastructure Bill: Senate Majority Leader Chuck Schumer’s (D-N.Y.) plan to pass a $550 billion infrastructure bill this week hit a potential obstacle when Sen. Lindsey Graham (R-S.C.) announced he tested positive for Covid-19 and will self-quarantine for 10 days. One of 10 Republicans who helped negotiate the infrastructure deal, Graham said he was tested yesterday after experiencing flu-like symptoms on Saturday. He said he was vaccinated.

The Senate doesn’t allow proxy voting like the House, so the quarantine would mean Graham would miss votes on the legislation, which Schumer wants passed before the end of the week. Graham’s vote alone wouldn’t necessarily hold up the deal. There were 67 votes last week to advance it, including 17 Republicans. Sixty votes will be needed finish the legislation. But the potential for a slew of more positive tests among senators in the chamber could upset that schedule. Laura Litvan and Steven Dennis have more.

• The infrastructure bill will create winners and losers among industries and companies that’ll be affected by what would be the government’s biggest public works spending spree in decades. Pharmacy benefit managers would be one winner. The bill would delay a Trump-era rule aimed at curbing the use of drug rebates, money refunded to PBMs from manufacturers often in exchange for preferred placement on a health plan’s formulary.
• Meanwhile, drugmakers may emerge as a loser under the deal. It carries a provision that would require drug manufacturers to refund Medicare for drug waste, medicine that’s discarded by doctors due to over-packaging. Medicare in 2019 paid more than $752 million for drugs that were discarded, federal government data show. Drugs made by Amgen, Celgene and Bristol-Myers Squibb contributed to over $150 million of that waste, data show, Laura Davison, Ari Natter and Steven Dennis report.

Democrats Push HHS on Drug Prices: Sens. Elizabeth Warren (D-Mass.) and Amy Klobuchar (D-Minn.) and Rep. Lloyd Doggett (D-Texas) asked HHS Secretary Xavier Becerra to update the lawmakers on the department’s use of tools like “Section 1498 compulsory licensing” and “Bayh-Dole march-in rights” to address drug prices, they said yesterday, referring to two laws dealing with government patent use including for patented drugs. Read the statement here.

The Coronavirus Pandemic

Biden Asks CDC to Weigh New Evictions Moratorium: Biden asked the Centers for Disease Control and Prevention to look into another extension of an evictions moratorium, but the agency’s leaders haven’t been able to legally justify it, Press Secretary Jen Psaki said. Biden made the request on Sunday, after a ban on evictions the CDC imposed expired a day prior. He was criticized by some in his own party for waiting until days before the ban’s expiration to ask lawmakers for an extension.

Treasury Secretary Janet Yellen will talk today to House Democrats about getting rental assistance out to more tenants. Congress has approved $46.5 billion in rent assistance since December, but most of that has not been sent out to Americans. Billy House has more.

U.S. Hits Biden’s Vaccination Goal, a Month Late: Seventy percent of U.S. adults have received at least one dose of a Covid-19 vaccine, a key milestone in the fight against the pandemic that the country hit nearly a month later than Biden had hoped. After falling considerably since April, the pace of vaccinations has recently accelerated due to the rapidly spreading delta variant. The country was averaging more than 72,000 new infections per day as of last Friday, the CDC said. Read more from Jennifer Epstein.

‘Very Real Fourth Wave’ Presses FDA to Approve Shots: A surge in Covid-19 cases across the U.S. is increasing pressure on U.S. drug regulators to fully approve Pfizer’s vaccine, the first one to apply for full licensure in the U.S. Full approval could help Biden’s administration ramp back up its immunization drive and reassure vaccine skeptics that the vaccines are safe. It could also make it easier for more schools and workplaces to mandate the shots. Bloomberg News spoke with Peter Marks, head of the FDA division reviewing Pfizer’s application.

Hospital Staffing Shortages Grow Sharply in Florida: The number of hospitals reporting critical staffing shortages is climbing swiftly in Florida, where the delta variant is filling beds fast. The Sunshine State faces 13% of its facilities reporting a shortage of medical personnel, up from 4% a week earlier, according to Health and Human Services Department data. That one-week surge was the most in the U.S., the data show. Florida accounted for nearly 20% of U.S. cases last week. Read more from Jonathan Levin.

Nursing Home Staff Said Size Fueled Covid-19 Spread: Nursing homes with larger staffs had about twice the rate of Covid-19 infections and deaths last year as those with fewer employees, new research has found. Facilities “in the lowest quartile of staff size had 6.2 resident cases” and nearly one death per 100 beds, compared with 11.9 cases and 2.1 deaths for facilities in the highest quartile, according to the study of more than 7,000 nursing homes published Monday in Health Affairs journal. Read more from Tony Pugh.

More U.S. Headlines:

• Biden to Deliver Remarks on Vaccines Today, White House Says
• San Francisco Bay Area Reinstates Mask Order as Covid-19 Surges
• Denver Mayor Requires City Workers Be Vaccinated by Sept. 30
• N.Y.C. Urges Masks as MTA Sets Shot-or-Tests Rule for Workers
• Judge Says Indiana University Vaccine Mandate Is Likely Lawful
• University of Mass. Students Sue Over Mandatory Vaccine Rule

More Global Headlines:

• Covid-10 Spikes in Wuhan as Delta Challenges China’s Defense
• Forecaster Who Saw Indian Virus Peak Sees New Wave Coming
• As Vaccinations Slow, Germany to Offer Vaccines to Ages 12-17
• French Vaccine Czar Sees Collective Immunity by Early Autumn

What Else to Know Today

Indiana’s Abortion Complications Reporting Law Upheld: An Indiana law requiring abortion providers to report complications to state authorities is constitutionally valid, because a reasonable person would understand what has to be reported, the Seventh Circuit said. The law doesn’t offend the “void-for-vagueness” doctrine, which mandates that criminal laws define an offense with enough clarity that most would be able to understand what’s prohibited, the Seventh Circuit said, Mary Anne Pazanowski reports.

Hospitals to Get $2.3 Billion Pay Hike From Medicare in 2022: Medicare will pay hospitals $2.3 billion more, a 2.5% hike, for inpatient stays in 2022, under a new rule issued yesterday by the Biden administration. Read more from Tony Pugh.

More Headlines:

• Kaiser Permanente Whistleblower Suits Get U.S.’s Involvement
• Self-Administered Plan Can Sue HHS for ACA Reinsurance Cash
• Bristol Myers Pulled Istodax PTCL Indication From U.S. Market
• Arriva, Parent Alere Agree to Pay $160M to Resolve Allegations
• Adapt Faces Tough Questions in Bid to Revive Narcan Patents

To contact the reporter on this story: Brandon Lee in Washington at blee@bgov.com

To contact the editors responsible for this story: Zachary Sherwood at zsherwood@bgov.com; Giuseppe Macri at gmacri@bgov.com; Michaela Ross at mross@bgov.com